The odorant metabolizing enzyme UGT2A1: Immunolocalization and impact of the modulation of its activity on the olfactory response.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 14 10 2020
accepted: 09 03 2021
entrez: 25 3 2021
pubmed: 26 3 2021
medline: 13 10 2021
Statut: epublish

Résumé

Odorant metabolizing enzymes (OMEs) are expressed in the olfactory epithelium (OE) where they play a significant role in the peripheral olfactory process by catalyzing the fast biotransformation of odorants leading either to their elimination or to the synthesis of new odorant stimuli. The large family of OMEs gathers different classes which interact with a myriad of odorants alike and complementary to olfactory receptors. Thus, it is necessary to increase our knowledge on OMEs to better understand their function in the physiological process of olfaction. This study focused on a major olfactory UDP-glucuronosyltransferase (UGT): UGT2A1. Immunohistochemistry and immunogold electronic microscopy allowed to localize its expression in the apical part of the sustentacular cells and originally at the plasma membrane of the olfactory cilia of the olfactory sensory neurons, both locations in close vicinity with olfactory receptors. Moreover, using electroolfactogram, we showed that a treatment of the OE with beta-glucuronidase, an enzyme which counterbalance the UGTs activity, increased the response to eugenol which is a strong odorant UGT substrate. Altogether, the results supported the function of the olfactory UGTs in the vertebrate olfactory perireceptor process.

Identifiants

pubmed: 33765098
doi: 10.1371/journal.pone.0249029
pii: PONE-D-20-32295
pmc: PMC7993815
doi:

Substances chimiques

Glucuronides 0
Pentanols 0
Receptors, Odorant 0
Eugenol 3T8H1794QW
amyl acetate 92Q24NH7AS
Glucuronosyltransferase EC 2.4.1.17
Glucuronidase EC 3.2.1.31

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0249029

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS One. 2013 Oct 10;8(10):e75716
pubmed: 24130737
PLoS One. 2013;8(3):e59547
pubmed: 23555703
Chem Senses. 2019 Sep 7;44(7):465-481
pubmed: 31254383
Drug Metab Rev. 2010 Feb;42(1):74-97
pubmed: 20067364
Chem Senses. 2016 Jan;41(1):15-23
pubmed: 26446453
Brain Res Mol Brain Res. 2001 May 20;90(1):83-92
pubmed: 11376859
Curr Drug Metab. 2005 Apr;6(2):141-60
pubmed: 15853765
J Biol Chem. 2015 Mar 20;290(12):7622-33
pubmed: 25586184
Drug Metab Dispos. 2011 Jul;39(7):1122-6
pubmed: 21460233
J Anat. 1974 Dec;118(Pt 3):477-89
pubmed: 4375676
J Biol Chem. 2002 Feb 8;277(6):4232-9
pubmed: 11714719
Mol Pharmacol. 1998 Jul;54(1):8-13
pubmed: 9658184
J Pharmacol Exp Ther. 2019 May;369(2):234-243
pubmed: 30850392
Biochem Pharmacol. 2009 May 1;77(9):1458-65
pubmed: 19150343
Drug Metab Rev. 2019 May;51(2):224-245
pubmed: 31203698
Pharmacogenet Genomics. 2011 Feb;21(2):55-65
pubmed: 21164388
Chem Senses. 2014 Jun;39(5):425-37
pubmed: 24718415
Biochem Pharmacol. 2019 May;163:335-344
pubmed: 30836059
J Hum Genet. 2002;47(10):505-10
pubmed: 12376738
Mol Cell Proteomics. 2014 Jul;13(7):1828-43
pubmed: 24748648
Xenobiotica. 2015 Mar;45(3):197-206
pubmed: 25259654
Sci Rep. 2018 Nov 21;8(1):17170
pubmed: 30464187
Biochem J. 1999 Jun 15;340 ( Pt 3):837-43
pubmed: 10359671
J Neurosci. 2010 Dec 1;30(48):16391-8
pubmed: 21123585
Brain Res Mol Brain Res. 2002 Nov 15;107(2):201-13
pubmed: 12425948
PLoS One. 2012;7(9):e45266
pubmed: 23024812
Neuropsychopharmacology. 2009 Feb;34(3):634-40
pubmed: 18668033
Sci Rep. 2017 Aug 31;7(1):10219
pubmed: 28860551
Eur J Biochem. 1994 May 15;222(1):91-6
pubmed: 8200358
J Neurophysiol. 2009 Jun;101(6):2898-906
pubmed: 19297511
Sci Rep. 2018 Dec 3;8(1):17554
pubmed: 30510230
Sci Rep. 2019 Feb 28;9(1):3104
pubmed: 30816217
PLoS One. 2019 Jul 24;14(7):e0220259
pubmed: 31339957
J Proteome Res. 2007 May;6(5):1985-96
pubmed: 17381150
Biochem Pharmacol. 1992 Apr 1;43(7):1649-53
pubmed: 1567486
J Pharmacol Exp Ther. 2012 Dec;343(3):712-24
pubmed: 22984225
Nature. 1991 Feb 28;349(6312):790-3
pubmed: 1900353
Sci Rep. 2019 Feb 21;9(1):2492
pubmed: 30792537
Xenobiotica. 2012 Mar;42(3):266-77
pubmed: 21995321
Anat Rec (Hoboken). 2013 Sep;296(9):1333-45
pubmed: 23907783
Proteomics. 2009 Jan;9(2):322-34
pubmed: 19086097
Chem Senses. 2020 Nov 7;45(8):645-654
pubmed: 32822468

Auteurs

Fabrice Neiers (F)

Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, CNRS, INRAE, Université Bourgogne Franche-Comté, Dijon, France.

David Jarriault (D)

Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, CNRS, INRAE, Université Bourgogne Franche-Comté, Dijon, France.

Franck Menetrier (F)

Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, CNRS, INRAE, Université Bourgogne Franche-Comté, Dijon, France.

Loïc Briand (L)

Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, CNRS, INRAE, Université Bourgogne Franche-Comté, Dijon, France.

Jean-Marie Heydel (JM)

Centre des Sciences du Goût et de l'Alimentation, AgroSup Dijon, CNRS, INRAE, Université Bourgogne Franche-Comté, Dijon, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH